For pain doctor Mark Wallace, arthritis meant his hobby of competitive swimming was becoming too painful.
“Every stroke was like an ice pick in my shoulder,” said Wallace, chief of the division of pain medicine at UC San Diego. Cortisone shots relieved the pain for about a month, and then it would return.
For philanthropist Denny Sanford, even walking was too painful. He sought relief for his arthritis with a right knee replacement, but that didn’t work well. So to treat his other knee, he looked for an alternative.
Wallace and Sanford said they found that relief with stem cells; Wallace at UC San Diego using cells from his bone marrow, and Sanford at a clinic in Germany using cells from his fat tissue. Their cases — particularly Wallace’s — illustrate how the use of stem cells to relieve joint pain is becoming an accepted part of orthopedic medicine.
With millions of baby boomers experiencing the miseries of arthritis, the need is great and growing.
Scott Wolf, CEO and Director of Research of Grace Century comments: “Regenerative medicine is gradually becoming part of mainstream healthcare and it is only a matter of time until it becomes essential. So watch our projects in this space.”
Read the rest of the article here.
MediXall Group, Inc., the medical network arm of Grace Century Electronic Medical Records (EMR) portfolio partner Quantum, has announced that its program to recruit and enlist licensed and certified healthcare providers to its Member Network has attracted almost 1,500 registrants.
The MediXaid platform provides a B2C capability that brings together into a single, cloud-based, patent-pending virtual marketplace the consumers of healthcare products and services with providers that compete on price, location and schedule for requested products and services.
MediXall Group Chairman, Noel J. Guillama , stated, “When I envisioned the MediXaid platform I believed that healthcare would soon be moving toward the need to providing greater access, transparency and competition for the consumer and to ensuring a broader reach into a greater segment of the community for healthcare providers. Clearly, this vision has proven accurate and now even the federal government is calling for exactly what we are providing through the MediXaid platform and MediXall Group, Inc. The positive response we are seeing from the Providers we are contacting is exciting and serves to underscore that both the consumer and provider are seeing the need for a platform like MediXaid.”
Scott Wolf, President and Director of Research for Grace Century, commented “The speed of uptake from healthcare providers to the MediXall member program is very impressive. The numbers achieved to date are already 6 months ahead of MediXall member targets, and this is an excellent indicator of the future growth potential of the MediXaid platform.”
Read the full press release here
Stem cell therapy is often a “last resort” treatment for patients with end-stage heart diseases. A recent study, however, finds that the treatment could be more harmful than helpful if cardiac stem cells are involved.
Researchers found that using patients’ own cardiac stem cells to repair damaged heart tissue may not only be ineffective but that the stem cells may also develop inflammatory properties that cause further heart damage.
In the United States, around 5.7 million adults are living with heart failure. The condition occurs when the heart is no longer able to pump enough oxygen-rich blood to fulfill the body’s needs.
There is currently no cure for heart failure. In some cases, the condition can be managed through medication and lifestyle changes. For people with end-stage heart failure, however, there are limited treatment options.
Heart transplantation remains the primary treatment for end-stage heart failure, but there are not enough donor hearts to meet recipient needs. Figures from the Organ Transplantation and Procurement Network show that there are more than 3,900 patients in the U.S. waiting for a heart transplant. Last year, 3,191 heart transplants were performed.
Scott Wolf, CEO and Director of Research for Grace Century comments: “These research findings confirm the obvious fact: stem cells from the sick hearts are not good and unusable, hence, banking from a young healthy person is the only way to secure the future health.”
Read the rest of the article here.
The legal battle to get patients access to stem cell therapy in Texas is closer to reality, according to TWCNews.com latest news article.
Texas Governor Greg Abbott signed such legislation into law this week, and it means some patients will be heading into uncharted medical territory.
After Sept. 1, patients with terminal illnesses or severe chronic diseases will be allowed to access experimental stem cell treatments in Texas.
Currently, most patients who want stem cell therapy have to travel outside the United States to do it, and stem cell re-injections are only allowed here within a 24-hour window.
“This is going to protect patient health, and provide for the treatments to be done here locally at home,” said Mike Byrom, the Chief Science Officer at Austin stem cell bank BioEden.
Byrom said the new law will keep patients in the country, and will provide renewed hope for those with serious ailments.
Scott Wolf, CEO and Director of Research of Grace Century commented: ”The recognition of Stem Cells treating aliments, and acceptance in Texas is cracking the flood gates open. Get the Insurance companies on board and it lights out!“
Read the rest of the article here.
Stem cell therapy is one step closer to becoming law in Texas, the latest state to push for passage of a patients’ “Right to Try” legislation. House Bill (HB) 810 is one of three proactive stem cell bills being considered in the Texas Legislature that would make it easier for those suffering with incurable illnesses to have access to stem cell treatments. The bill, which passed the Texas House unanimously, now heads over to the Senate.
Scott Wolf, CEO and Director of Research for Grace Century comments: “This kind of legislation, hopefully will be controlled, but moves the goal post closer for the industry. Personally, I am waiting for Insurance companies to agree to pay for storage of young healthy cells: to me that’s a no brainer for improving health down the road, while saving tons of cash.”
Read the rest of the article on WAFB
It has recently been reported on Yahoo! News that MediXall Group, Inc., who are the medical network arm of Grace Century Electronic Medical Records (EMR) portfolio partner Quantum, have announced the launch of Phase 2 in the recruitment of Healthcare Providers. This has been done with the Provider Development Website, which has been designed to speed-up the enlisting of selected physician practices, diagnostic centers and medical services companies to the MediXaid Platform.
MediXall Group Chief Operating Officer, Carl Larsen, stated, “We are excited by the overwhelmingly positive response we are receiving from healthcare practices to join the MediXaid® Provider Network. We believe we have developed a strong marketing and sales program that will both facilitate the rapid development of a strong healthcare provider network in the South Florida are, plus will further serve as a foundation for expanding our reach throughout the State and nationwide.”
Grace Century President and Director of Research Scott Wolf said “Fresh Out of the box, Grace Century and Quantum’s Portfolio firm is moving forward fast. We are so excited for this firm, with Beta testing expected over the summer.”
Read the full article on Yahoo! News by clicking here.
A recent article on ZD Net takes a look at cloud computing / technology and how it the business models to generate revenue from related products have evolved over the years.
Our electronic medical records partner The Quantum Group Inc, have developed an innovative cloud- based system known PWeR, which a shortened version of Personal Wellness Record. Quantum currently employs a subscription model, which interestingly is how most the companies who use cloud technology in other industries – Amazon being a prime example – are structuring their business models.
Scott Wolf, President and Director of Research for Grace Century, commented “this is an interesting article on the subject of cloud technology, and from our perspective is it notable that Quantum have taken a commercial path which is similar to that of cutting-edge industry giants in other technology-based market sectors. The difference between the healthcare sector and other market sectors is that the use of cloud computing and related technology is very much behind in the healthcare sector, and Quantum are one of the very few companies in this sector who have embraced such technology at a best-practice level.”
Read the full article on ZD Net by clicking here.
Provia Labs, Grace Century’s dental stem cell storage system portfolio project, has been features in an article on CNN on how dental cells could represent the next stage in the development of the emerging science of stem cell treatment.
The article, which is a lengthy and comprehensive feature, includes contributions from Dr. Joseph C. Laning, chief technology officer of Provia Laboratories LLC. The piece tries to balance the increasingly rigorous scientific case for the increased potential of stem cells as a method of treating complex disorders like multiple sclerosis (MS) and traumatic brain injury, with some more cautious views from the scientific community.
Scott Wolf, President and Director of Research for Grace Century, commented “The fact that our portfolio project, Provia labs, has made it to CNN, simply serves to highlight the traction that stem cells and their significant future potential for the treatment of many conditions has gained in the medical world. Whilst the article includes the views of some of the more skeptical members of the community, it should be noted that The President of the American Academy of Pediatric Dentistry, Dr. Jade Miller endorses the storage of baby teeth / Wisdom teeth and has done so himself for his family. In addition, the opinion of professional medical bodies is no guarantee of anything as Dr. N (Advisor for Provia) discovered for himself with regard to the National Bone Registry as we reported on our blog article of last May.”
Read the full CNN article by clicking here.
Annual Investment Meeting (AIM) Startup 2017 kicked off in Dubai, under the patronage of his Highness Sheikh Mohammed Bin Rashid al Maktoum, Vice President and Prime Minister of the U.A.E. and Ruler of Dubai. In cooperation with the Ministry of the Economy, and over 3 days, attendees were able to network and listen to presentations with multiple speakers from different niches within finance.
The event is a platform where disruptive Start-ups gather to present their innovative products and services on a truly global stage.
The discussions gave a unique insight to the present and future climate that ‘Early” stage firms might be confronted with. These included many discussions from Building Global companies all the way to the “Do’s and Don’ts” with the interaction of Government agencies. The event was highlighted by providing a platform for 84 young companies, from many countries, to have an opportunity to be in front of interested funding partners.
Grace Century Members Jennifer Doyle, Vice President of Administration and CEO, Scott Wolf attended. Wolf comments “I was thoroughly impressed with the innovations brought to the competition, especially the high concentration of companies from the Emirates. It is a testament to how the country has provided a nurturing infrastructure and why it is home to some many “incubators””.
Presenting to the groups were Start-ups and early stage firms coming from Food & Beverage, Agriculture, Renewable Energy, Healthcare, and Education.
Scott Wolf concludes “Expos like this are not only invaluable to see possible “project flow” for our firm, but to keep on finger on the rapidly changing landscape in this stage of firms and the changing technologies. The fact that it was in our “backyard” of Dubai was an added benefit”.
It has been announced that Grace Century President and Director of Research Scott Wolf has has appointed to the Business Advisory Board of Provia Laboratories LLC, Grace Century’s dental stem cell storage project partner.
Scott has tirelessly worked to help Provia with many important business functions since becoming involved with them in 2014, including contributing to Provia’s overall strategy, new business & market development, and raising of capital. Though the Grace Century members’ network, almost $10 million of funding has been secured for Provia.
Read Provia’s full press release on Scott’s apportionment here.